智通财经APP讯,康臣药业(01681)发布以下董事局提名委员会组成变动,自2025年6月20日起生效:
(1)董事局主席兼执行董事安勐先生已不再担任提名委员会成员;及
(2)非执行董事张丽华博士已获委任为提名委员会成员。
经上述变动后,提名委员会将由3名成员组成,即李义凯教授(主席)、张丽华博士及段威武先生。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.